MM
Therapeutic Areas
Cryo-Cell Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Cryo-Cell Processed Cord Blood Unit | Hematologic malignancies, bone marrow failure, metabolic & immune disorders (via HSC transplant) | Commercial |
| Cord Tissue Mesenchymal Stem Cell Banking | Potential regenerative medicine applications (investigational) | Pre-clinical |
| C'elle® (Menstrual Stem Cell Banking) | Potential regenerative medicine applications (investigational) | Pre-clinical |
Leadership Team at Cryo-Cell
DP
David Portnoy
Chairman of the Board and Co-Chief Executive Officer
ML
Mark L. Portnoy
Co-Chief Executive Officer and Director
MB
Markus Boehm
Director
JH
Jonathan H. Wheeler
Director
TC
Todd C. Wood
Director
KR
Kurt R. O'Bryan
Director
LL
Linda L. Kelley
Scientific Advisor (Former Chief Scientific Officer)